Clinical outcome of chemoradiotherapy in patients (pts) with limited-disease small-cell lung cancer (LD-SCLC) with ipsilateral pleural effusion

被引：1
|
作者：
Niho, S. [1 ]
Kubota, K. [1 ]
Yoh, K. [1 ]
Goto, K. [1 ]
Ohmatsu, H. [1 ]
Saijo, N. [1 ]
Nishiwaki, Y. [1 ]
机构：
[1] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CONCURRENT VERSUS SEQUENTIAL CHEMORADIOTHERAPY IN LIMITED-DISEASE SMALL-CELL LUNG CANCER: A RETROSPECTIVE COMPARATIVE STUDY
    El Sharouni, Sherif Y.
    Kal, Henk B.
    Rijbroek, Angelique Barten-Van
    Struikmans, Henk
    Battermann, Jan J.
    Schramel, Franz M. N. H.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3273 - 3274
  • [22] Isolated nodal failure after chemo-radiotherapy in limited disease small cell lung cancer (LD-SCLC)
    Wierzchowski, Marek
    Sprawka, Arkadiusz
    Kepka, Lucyna
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2009, 14 (02) : 58 - 63
  • [23] Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604
    Misumi, Yuki
    Okamoto, Hiroaki
    Sasaki, Jiichiro
    Masuda, Noriyuki
    Ishii, Mari
    Shimokawa, Tsuneo
    Hosomi, Yukio
    Okuma, Yusuke
    Nagamata, Makoto
    Ogura, Takashi
    Kato, Terufumi
    Sata, Masafumi
    Otani, Sakiko
    Takakura, Akira
    Minato, Koichi
    Miura, Yosuke
    Yokoyama, Takuma
    Takata, Saori
    Naoki, Katsuhiko
    Watanabe, Koshiro
    BMC CANCER, 2017, 17 (1)
  • [24] Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604
    Yuki Misumi
    Hiroaki Okamoto
    Jiichiro Sasaki
    Noriyuki Masuda
    Mari Ishii
    Tsuneo Shimokawa
    Yukio Hosomi
    Yusuke Okuma
    Makoto Nagamata
    Takashi Ogura
    Terufumi Kato
    Masafumi Sata
    Sakiko Otani
    Akira Takakura
    Koichi Minato
    Yosuke Miura
    Takuma Yokoyama
    Saori Takata
    Katsuhiko Naoki
    Koshiro Watanabe
    BMC Cancer, 17
  • [25] Is the total dose of importance in thoracic radiotherapy of small-cell lung cancer (SCLC) limited disease (LD)?
    Hallqvist, A
    Nyman, J
    Rylander, H
    LUNG CANCER, 2005, 49 : S320 - S321
  • [26] Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
    Xu, Yong-jie
    Zheng, Hui
    Gao, Wen
    Jiang, Ge-ning
    Xie, Hui-kang
    Chen, Chang
    Fei, Ke
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2014, 19 (06) : 887 - 893
  • [27] Limited-disease small-cell lung cancer research: Sense and nonsense
    Turrisi, AT
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (04): : 925 - 927
  • [28] Intensive chemotherapy and radiation therapy in patients with limited-disease small-cell lung cancer
    Panoussaki, E
    Samantas, E
    Fountzilas, G
    Pavlidis, E
    Kosmas, E
    Tsiakopoulos, E
    RADIOLOGY, 1996, 201 : 1501 - 1501
  • [29] Evaluating the safety of using G-CSF prophylaxis during concurrent thoracic chemo-radiotherapy (CTRT) in patients with limited-disease small-cell lung cancer (LD-SCLC): Evidence from a phase II trial
    Sheikh, H. Y.
    Colaco, R.
    Ashcroft, L.
    Blackhall, F. H.
    Lorigan, P. C.
    Taylor, P.
    Thatcher, N.
    LUNG CANCER, 2010, 67 : S10 - S11
  • [30] The results of combined modality therapy for limited stage small cell lung cancer (LD-SCLC) in the elderly.
    Schild, SE
    Stella, PJ
    Brooks, BJ
    Mandrekar, S
    Bonner, JA
    McGinnis, WL
    Nikcevich, DA
    Adjei, AA
    Jatoi, A
    Jett, JR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 627S - 627S
12345